UMass Chan Medical School and Curai Health Partner to Provide Virtual Care for COVID-19 and Flu Study Participants

What You Should Know:  – UMass Chan Medical School and Curai Health, a provider of virtual care solutions, today announced a partnership to provide free virtual care visits to participants enrolled in the STOP COVID-19 research study.  – The collaboration aims to enhance access to care for individuals who test positive for COVID-19 or influenza ... Read More

Feb 24, 2025 - 20:59
 0
UMass Chan Medical School and Curai Health Partner to Provide Virtual Care for COVID-19 and Flu Study Participants

What You Should Know: 

– UMass Chan Medical School and Curai Health, a provider of virtual care solutions, today announced a partnership to provide free virtual care visits to participants enrolled in the STOP COVID-19 research study

– The collaboration aims to enhance access to care for individuals who test positive for COVID-19 or influenza and contribute to a better understanding of home-based testing for these viruses.

STOP COVID-19 Study

The STOP COVID-19 study, funded by the National Institutes of Health, is investigating the performance of rapid antigen tests compared to PCR tests in detecting COVID-19 after the onset of symptoms. Participants in the study who test positive for COVID-19 or the flu will now have access to Curai Health’s virtual care platform, where they can connect with licensed clinicians for diagnosis, treatment, and management of their condition.

Through this partnership, study participants will have access to:

  • Free virtual care visits: Connect with licensed clinicians for diagnosis and management of COVID-19, influenza, and other medical needs.
  • Convenient and accessible care: Receive care from the comfort of their own homes, eliminating the need for travel to a clinic or hospital.
  • Personalized treatment plans: Benefit from AI-powered insights and personalized treatment recommendations.

“Improving at-home testing for COVID-19 is an important first step, but it needs to be paired with getting clinical care because these respiratory viruses still cause significant disease and deaths. Rapid access to a clinician that can prescribe the appropriate treatment is necessary but often hard for patients, especially if they are self-isolating,” said Apurv Soni, MD, PhD’21, assistant professor of medicine and co-director of the Program in Digital Medicine at UMass Chan Medical School. Dr. Soni is the study’s principal investigator. “With Curai, our participants will have the option to either seek care on their own or instantaneously receive quality virtual care from the safety and convenience of their home.”